Results 61 to 70 of about 12,516 (121)

Tick-Borne Viruses: Transmission and Surveillance. [PDF]

Viruses
Papa A.
europepmc   +1 more source

Projecting tick-borne encephalitis risk in Sweden under climate change scenarios: a high-resolution spatio-temporal modeling approach. [PDF]

Environ Health
Sewe MO, Wallin J, Rocklöv J, Wang S, Koenigk T, Semenza JC.   +5 more
europepmc   +1 more source

Co-Feeding Transmission of Tick-Borne Viruses. [PDF]

Viruses
Macon-Foley SC, Hermance ME.
europepmc   +1 more source

Identification and Phylodynamic Analysis of the Siberian Subtype of Tick-Borne Encephalitis Virus in Tick-Bitten Patients From Northeastern China. [PDF]

Transbound Emerg Dis
Wei Z, Liu Z, Liu Y, Liu N, Ren Y, Han S, Zheng X, Lv X, Wang Z.   +8 more
europepmc   +1 more source

A novel integrated Markov-based model for vaccine cost-effectiveness in Lyme borreliosis and tick-borne encephalitis: implications for further research. [PDF]

Front Med (Lausanne)
Šmit R.
europepmc   +1 more source

Distinct cerebrospinal fluid microbiome dysbiosis associated with disease severity in tick-borne encephalitis

Chaopreecha J, Suyema S, Fořtová A, Pychova M, Krbkova L, Blair GE, Sheppard SK, Ruzek D, Goonawardane N.   +8 more
europepmc   +1 more source

Langat Virus Infection Can Be Demonstrated in Both Tick Salivary Glands and Midgut Within 24 Hours of Blood Feeding. [PDF]

Viruses
Ochwoto M, Offerdahl DK, Ogola EO, Weck BC, Long D, Saturday GA, Bloom ME.   +6 more
europepmc   +1 more source

Predicting the spatio-temporal risk of human tick-borne encephalitis (TBE) in Europe by combining hazard and exposure drivers. [PDF]

One Health
Dagostin F, Erazo D, Marini G, Da Re D, Tagliapietra V, Avdicova M, Avšič-Županc T, Dub T, Fiorito N, Knap N, Gossner CM, Kerlik J, Mäkelä H, Markowicz M, Olyazadeh R, Richter L, Wint W, Zuccali MG, Žygutienė M, Dellicour S, Rizzoli A.   +20 more
europepmc   +1 more source

Correction: Müller et al. Does the Vaccination Against Tick-Borne Encephalitis Offer Good Value for Money for Incidence Rates Below the WHO Threshold for Endemicity? A Case Study for Germany. <i>Vaccines</i> 2024, <i>12</i>, 1165. [PDF]

Vaccines (Basel)
Müller M, Lintener H, Henkel V, Pilz A, Halsby K, Malerczyk C, Madhava H, Moïsi JC, Yu H, Schley K.   +9 more
europepmc   +1 more source